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Abstract
HHV-6 has been identified as the aetiologic agent of exanthem subitum in infants and an acute
febrile illness in young children. HHV-6 probably remains latent in the body after the primary
infection and it reactivates upon host immunosuppression in a manner similar to other human
herpes viruses. Primary HHV-6 infection in adults is very rare and it is not clear whether disease
manifestations are similar to those observed in children.
We report the case of acute hepatitis in a 18-year-old immunocompetent woman presenting with
sever jaundice and liver dysfunction. Serum immunoglobulin levels were elevated (3.8 gr/dl) with a
titre of anti nucleus antibody of 1:640. Serological data demonstrated the presence of IgM
antibodies against human herpesvirus-6 in the serum and of viral DNA on liver biopsy by real time
quantitative polymerase chain reaction, with a viral load of 280 genomes/106 of cellular genomes.
No other etiologic agents were found to induce hepatitis and the patient was diagnosed as having
HHV-6 triggered autoimmune acute hepatitis.
Introduction
Human herpesvirus 6 (HHV-6) was first isolated from
patients with the acquired immunodeficiency syndrome
or lymphoproliferative diseases and was named human B
lymphotropic virus [1]. HHV-6 has been identified as the
etiologic agent of exanthema subitum in infants [2] and
an acute febrile illness in young children [3]. Most people
are seropositive for HHV-6 by the age of three years [4].
HHV-6 also produces latent or chronic infections [5] and
is occasionally reactivated in immunocompromised hosts
[1,6]. Furthermore, HHV-6 has been implicated in several
diseases in immunocompetent adults, including Kikuchi's
lymphadenitis [7] and an infectious mononucleosis-like
syndrome that is negative for Epstein-Barr virus and
cytomegalovirus [8]. We describe the immunopathologi-
cal and clinical features of a severe acute hepatitis in a 18-
year-old woman that was probably caused by a primary
infection with HHV-6.
Case presentation
A 18-year-old woman was admitted to S.Caterina Novella
Hospital on October 10, 2006, with a fifteenday history of
flu-like syndrome. She had been healthy and had a history
of self-limiting viral infections including measles and
rubella in childhood. Physical examination revealed left
cervical lymphadenopathy, splenomegaly and sever jaun-
dice. Abnormal laboratory findings included a white
blood cell count of 4.9 × 109/L (3% atypical lymphocytes)
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with large granular cells and anisocytosy in peripheral
smear.
Liver dysfunction was seen, with an increase in the levels
of aspartate aminotransferase (1515 IU/l), alanine ami-
notransferase (1658 IU/l), lactate dehydrogenase (1080
IU/l) and total bilirubin (18.6 mg/dl). Prothrombin time
was 28%. Serum immunoglobulin levels were elevated
(3.8 gr/dl) with a titre of anti nucleus antibody (ANA) of
1:640. No antibodies against human immunodeficiency
virus (HIV), hepatitis C virus (HCV), Hepatitis B virus
(HBV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV)
were detected. However anti-HHV-6 antibody (IgG and
IgM) were detected with IgM index of 3.2 (cut off for pos-
itive control > 1.1). A diagnosis of hepatic failure was
made, and liver biopsy was performed during the acute
stage. Histologic examination showed moderate infiltra-
tion of atypical lymphoid cells and diffuse focal vacuolar
degeneration of hepatocytes. The infiltrating lymphocytes
were positive for CD3, CD4, and CD8, but negative for
CD20. The presence of HHV-6 DNA was shown in liver
tissue by polymerase chain reaction (PCR) with a viral
load of 280 genomes/106 of cellular genomes, suggesting
active viral replication in the hepatocytes. Methylpred-
nisolone was administered for three weeks beginning on
the seventh day of hospitalization with dosage of 25 mg
every twelve hours. The jaundice, lymphadenopathy and
splenomegaly gradually disappeared and patient was sent
home on the 35th hospital day with a normal hepatic
function and no clinical sequelae. At 2 months HHV6 IgM
antibodies decreased and disappeared after 3 months.
Discussion
Our data indicate that HHV-6 was the cause of our
patient's acute illness. Serologic studies excluded the pos-
sibility of active infection by HCV, HBV or other human
herpesviruses such CMV and EBV. The presence of HHV-6
IgM antibodies shortly after the onset of liver disease and
positive ANA titres suggest that HHV6 or an autoimmune
disease may also be involved in the pathogenesis. HHV-6
is a CD4 lymphotropic virus isolated from T-cells cultures
derived from the blood of subjects HIV+ [1]. Infection by
HHV6 is rapidly controlled by the host immune response,
and the virus established a state of latency. Primary infec-
tion occurs mostly in early childhood and only rarely in
adults, in whom the prevalence of anti-HHV6 IgG is more
than 90% [3]. Symptomatic infection is characterized by
fever, skin rash (exanthema subitum), sometimes associ-
ated with mild respiratory illness, leukopenia and atypical
lymphocytosis [3,10]. Recovery is usually rapid and
benign, although a more severe course with meningitis,
encephalitis, myocarditis or hepatitis, variable from mild
hepatitis to fulminant liver failure, has been described [3].
HHV6 has also been associated with interstitial pneumo-
nia and encephalitis in immunocompromised patients.
[11] We assume that HHV-6 caused the initial clinical
manifestations but an humoral virus-triggered autoim-
mune reaction, indicated by the positive ANA titre,
responding to immunosuppression induced hepatic dam-
age. Manifestations of autoimmune hepatitis have been
described repeatedly after infection with hepatitis A, B and
C as well as with herpes viruses, namely HSV1, EBV and
HHV6 [12,13].
Conclusion
Autoantibodies may be triggered by a virus specific mech-
anism to evade immune responses called 'molecular mim-
icry', when domains on viral proteins closely resembling
human self-epitopes are generated [14,15]. Thus, we
believe that in addition to causing exanthem subitum in
infants and a febrile illness in children, HHV-6 type B can
cause an acute and potentially fulminant hepatitis in
adults with an autoimmune pathogenetic mechanism.
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